Innovation
featured
SAN FRANCISCO, May 17- Strong debuts in the initial public offerings of two business software companies on Friday underscored a pattern in the market: While consumer companies like Facebook Inc get the buzz, enterprise companies are racking up most of the market gains.
» Read More
More
-
Gregory Sorenson, President and CEO of Siemens Healthcare North America, discusses repealing the medical device tax.
-
NEW YORK, May 7- David Einhorn's Greenlight Capital has added to its investment position in Apple Inc. In a conference call for his Cayman Islands- based reinsurer Greenlight Capital Re Ltd, Einhorn did not specify when the hedge fund added to its Apple position or the size of its current holdings.
-
BMC Software said on Monday it agreed to be acquired by a private-equity group led by Bain Capital and Golden Gate Capital for about $6.9 billion.
-
Bill Gates, Microsoft chairman; and Warren Buffett, Berkshire Hathaway, chairman & CEO, discuss the importance of measuring innovation and intervention. Also, both business leaders take a look at increasing the awareness of philanthropy and the U.S. government's role in providing financial aid to poorer countries.
-
*FDA clears Masimo rainbow acoustic Monitoring (TM) sensor for use on.
-
There's little doubt that the 20th century was full of breakthroughs that changed history. But the 21st century could go a step further, according to Citi.
-
SHANGHAI, May 6- Amazon.com Inc launched an Android application store that offers paid apps in China, beating Google Inc, as the online retailer seeks to increase the amount of digital content it offers in the world's largest mobile phone market.
-
Muse Founder & CEO Kathryn Minshew delivers her 60 second Power Pitch to CNBC host Brian Sullivan; Dan Rosensweig Chegg President & CEO, and Julia Boorstin CNBC Media & Entertainment Reporter.
-
Manufacturers are gravitating toward wireless connections for Apple’s products, which is helping the market for competitors’ mobile devices.
-
There's a potentially huge marketplace being born for second-hand digital content, but can it can survive the challenges to its existence.
-
May 3- The U.S. Food and Drug Administration approved a Merck& Co. cholesterol lowering pill that combines a generic version of Pfizer Inc's Lipitor with its own Zetia, Merck said on Friday. Vytorin, which had sales of $1.75 billion in 2012, is currently undergoing a long-term trial to prove that it can reduce heart attacks and strokes better than Zocor alone.
-
Concerns over domestic surveillance aside, the industry says 100,000 jobs could eventually be created if the FAA integrates drones into U.S. airspace by its 2015 target date.
-
May 3- Mueller Water Products Inc:. *RBC raises target price to $8 from $7; rating outperform. Reuters Station users, click. 1568.
-
May 3- Bristol-Myers Squibb Co:. *Receives US FDA sNDA approval for use of sustiva in hiv-1. infected pediatric patients* Source text for Eikon* Further company coverage ().
-
*Pfizer, Amgen, AstraZeneca among firms placing bets. LONDON, May 3- Is nanomedicine the next big thing? Three deals struck this year by privately held Bind Therapeutics, together worth nearly $1 billion if experiments are successful, highlight a new interest in using such tiny carriers to deliver drug payloads to specific locations in the body.
-
*Pfizer, Amgen, AstraZeneca among firms placing bets. LONDON, May 3- Is nanomedicine the next big thing? Three deals struck this year by privately held Bind Therapeutics, together worth nearly $1 billion if experiments are successful, highlight a new interest in using such tiny carriers to deliver drug payloads to specific locations in the body.
-
Ronald Perelman, MacAndrews & Forbes chairman & CEO; Glenn Hubbard, Columbia Business School dean; and CNBC's Robert Frank discuss whether higher taxes will solve the nation's fiscal problems and weigh in on limiting the size of banks.
-
May 2- Enterprise Products Partners LP:. For a summary of rating and price target changes on U.S. companies: Reuters Eikon users, click on RCH/US Reuters 3000 Xtra users, double-click RCH/US Reuters Station users, click. 1568.
-
In the third part of an exclusive CNBC interview, Ronald Perelman, MacAndrews & Forbes chairman & CEO, shares his views on dealmaking, political leadership, and tax reform, with Glenn Hubbard, Columbia Business School dean; and CNBC's Robert Frank.
-
In the second part of an exclusive CNBC interview, Ronald Perelman, MacAndrews & Forbes chairman & CEO, discusses how the lack of demand by consumers is disrupting business growth, with Glenn Hubbard, Columbia Business School dean; and CNBC's Robert Frank
